Screening for hepatocellular carcinoma

Ayman Koteish, Paul J. Thuluvath

Research output: Contribution to journalReview articlepeer-review


To determine the role of screening and to screen in a cost-effective manner, it is important to define the high-risk patient population that is most likely to benefit from screening and to identify a readily available diagnostic modality that is sensitive, specific, and inexpensive. Moreover, to have a major effect on the outcome of hepatocellular carcinoma, the test should be applicable in the majority of high-risk subjects. Herein, we identify the high-risk patient population, discuss various diagnostic modalities, and recommend a practical and cost-effective strategy for screening.

Original languageEnglish (US)
Pages (from-to)S185-S190
JournalJournal of Vascular and Interventional Radiology
Issue number9 II
StatePublished - Sep 1 2002


  • Liver neoplasms, CT
  • Liver neoplasms, MR
  • Liver neoplasms, US
  • Liver neoplasms, diagnosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Screening for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this